Syocin Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Syocin Corporation - overview
Established
2019
Location
-, -, Argentina
Primary Industry
Biotechnology
About
Based in Argentina, and founded in 2019 by Julia Roulet and Marcos Delas, Syocin Corporation, also known as Syocin Biotech, operates as a biotechnology company. In March 2022, Syocin Corporation raised an undisclosed amount of seed funding led by new investor Blue Horizon Corporation, with participation from other new investors Gisev Family Office and GRID EXPONENTIAL. Syocin provides non-toxic, biodegradable protein-based solutions for bacterial disease protection in agricultural crops. The company offers a synthetic biology platform that can design and create high-precision bactericidal proteins to produce each bio-bactericide solution in months rather than years.
The company plans to use the March 2022 funds to achieve its ambition to replace harmful chemicals with precision biology, delivering healthier food to all.
Current Investors
GRID EXPONENTIAL, Blue Horizon, Gisev Family Office
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.syocin.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.